BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PPARA
,
Metabolism of xenobiotics
,
Pseudomonas infection
,
Lymphocyte
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cognitive enhancers
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
RRM2
FOS
CDK1
ACHE
CA1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
regulation of nitrogen compound metabolic process
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
PUJANA_BRCA1_PCC_NETWORK
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Cortical neurons exposed to excitotoxic NMDA and potentially neuroprotective compounds
Liver progenitor cell lines derived from mice with liver injury
Spleens, livers or kidneys from male mice fed with choline and folic acid-deficient diet
Hodgkin's lymphoma cell lines treated with kinase inhibitors perifosine, givinostat and sorafenib
Yeast cultured in nutrient-limiting conditions with snf1-deletions and inositol/choline treatment.
Explore Curated Studies Results
Literature
Most Relevant Literature
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
Cognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enz…
Plant-derived nootropics and human cognition: A systematic review.
Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.
Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Putative Cognitive Enhancer VU319
Multiple Ascending Dose Putative Cognitive Enhancer VU319
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
Cognitive Enhancement Therapy for Early-Stage Schizophrenia
Cognitive Training and Enhanced Supported Employment in Schizophrenia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ